A novel in vitro bovine cartilage punch model for assessing the regeneration of focal cartilage defects with biocompatible bacterial nanocellulose

Arthritis Research and Therapy

Volumn 15, Issue 3, 2013, Pages

  Pretzel, David ^a   Linss, Stefanie ^a   Ahrem, Hannes ^a,b   Endres, Michaela ^c   Kaps, Christian ^c   Klemm, Dieter ^d   Kinne, Raimund W ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Jenpolymer Materials Ltd and Co KG   (Germany)

^c TRANSTISSUE TECHNOLOGIES GMBH   (Germany)

^d Polymet Jena eV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; BIOMATERIAL; CELLULOSE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; NANOMATERIAL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE CELL; CHONDROGENESIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMPLANT; IN VITRO STUDY; NONHUMAN; TISSUE REGENERATION; ANIMAL; ARTICULAR CARTILAGE; CATTLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCONACETOBACTER XYLINUS; METABOLISM; METHODOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARTILAGE, ARTICULAR; CATTLE; CELLULOSE; CHONDROCYTES; CHONDROGENESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCONACETOBACTER XYLINUS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; NANOSTRUCTURES; REAL-TIME POLYMERASE CHAIN REACTION; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

EID: 84877603769     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4231     Document Type: Article

References (92)

1. Hardingham TE, Fosang AJ, Dudhia J. Aggrecan, the chondroitin/ keratin sulfate proteoglycan from cartilage. Articular Cartilage and Osteoarthritis 1992, 5-20. New York: Raven Press, Kuettner KE, Peyron J, Schleyerbach R, Hascall VC.
2. Khan IM, Gilbert SJ, Singhrao SK, Duance VC, Archer CW. Cartilage integration: evaluation of the reasons for failure of integration during cartilage repair. A review. Eur Cell Mater 2008, 16:26-39.
3. Steinwachs MR, Guggi TH, Kreuz PC. Marrow stimulation techniques. Injury 2008, 39:S26-S31. 10.1016/j.injury.2008.01.042, 18313469.
4. Behrens P, Bosch U, Bruns J, Erggelet C, Esenwein SA, Gaissmaier C, Krackhardt T, Löhnert J, Marlovits S, Meenen NM, Mollenhauer J, Nehrer S, Niethard FU, Nöth U, Perka C, Richter W, Schäfer D, Schneider U, Steinwachs M, Weise K, . German Society for Traumatology, German Society for Orthopedic Surgery Indications and implementation of recommendations of the working group "Tissue Regeneration and Tissue Substitutes" for autologous chondrocyte transplantation (ACT). Z Orthop Ihre Grenzgeb 2004, 142:529-539. [In German], 10.1055/s-2004-832353, 15472761, German Society for Traumatology, German Society for Orthopedic Surgery.
5. Brown WE, Potter HG, Marx RG, Wickiewicz TL, Warren RF. Magnetic resonance imaging appearance of cartilage repair in the knee. Clin Orthop Relat Res 2004, 422:214-223.
6. Sledge SL. Microfracture techniques in the treatment of osteochondral injuries. Clin Sports Med 2001, 20:365-377. 10.1016/S0278-5919(05)70311-2, 11398363.
7. Temenoff JS, Mikos AG. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 2000, 21:431-440. 10.1016/S0142-9612(99)00213-6, 10674807.
8. Klemm D, Schumann D, Kramer F, Hessler N, Hornung M, Schmauder HP, Marsch S. Nanocelluloses as innovative polymers in research and application. Polysaccharides 2006, 205:49-96.
9. Hessler N, Klemm D. Alteration of bacterial nanocellulose structure by in situ modification using polyethylene glycol and carbohydrate additives. Cellulose 2009, 16:899-910.
10. Klemm D, Schumann D, Udhardt U, Marsch S. Bacterial synthesized cellulose-artificial blood vessels for microsurgery. Prog Polym Sci 2001, 26:1561-1603.
11. Helenius G, Backdahl H, Bodin A, Nannmark U, Gatenholm P, Risberg B. In vivo biocompatibility of bacterial cellulose. J Biomed Mater Res A 2006, 76:431-438.
12. Chen YM, Xi TF, Zheng YD, Guo TT, Hou JQ, Wan YZ, Gao C. In vitro cytotoxicity of bacterial cellulose scaffolds used for tissue-engineered bone. J Bioact Compat Pol 2009, 24:137-145.
13. Pattison MA, Wurster S, Webster TJ, Haberstroh KM. Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications. Biomaterials 2005, 26:2491-2500. 10.1016/j.biomaterials.2004.07.011, 15585251.
14. Czaja WK, Young DJ, Kawecki M, Brown RM. The future prospects of microbial cellulose in biomedical applications. Biomacromolecules 2007, 8:1-12. 10.1021/bm060620d, 17206781.
15. Schumann DA, Wippermann J, Klemm DO, Kramer F, Koth D, Kosmehl H, Wahlers T, Salehi-Gelani S. Artificial vascular implants from bacterial cellulose: preliminary results of small arterial substitutes. Cellulose 2009, 16:877-885.
16. Wippermann J, Schumann D, Klemm D, Kosmehl H, Satehi-Gelani S, Wahlers T. Preliminary results of small arterial substitute performed with a new cylindrical biomaterial composed of bacterial cellulose. Eur J Vasc Endovasc Surg 2009, 37:592-596. 10.1016/j.ejvs.2009.01.007, 19231251.
17. Lang N, Sigler M, Merkel E, Fuchs F, Schumann D, Klemm D, Kramer F, Meyer A, Freudenthal F, Schroeder C, Mayer S, Netz H, Kozlik-Feldmann R. Evaluation of bacterial cellulose as a new patch material for closure of muscular ventricular septal defects. J Am Coll Cardiol 2010, 55:A43-E412.
18. Bodin A, Concaro S, Brittberg M, Gatenholm P. Bacterial cellulose as a potential meniscus implant. J Tissue Eng Regen Med 2007, 1:406-408. 10.1002/term.51, 18038435.
19. Hutchens SA, Benson RS, Evans BR, O'Neill HM, Rawn CJ. Biomimetic synthesis of calcium-deficient hydroxyapatite in a natural hydrogel. Biomaterials 2006, 27:4661-4670. 10.1016/j.biomaterials.2006.04.032, 16713623.
20. Svensson A, Nicklasson E, Harrah T, Panilaitis B, Kaplan DL, Brittberg M, Gatenholm P. Bacterial cellulose as a potential scaffold for tissue engineering of cartilage. Biomaterials 2005, 26:419-431. 10.1016/j.biomaterials.2004.02.049, 15275816.
21. Barone-Varelas J, Schnitzer TJ, Meng Q, Otten L, Thonar EJ. Age-related differences in the metabolism of proteoglycans in bovine articular cartilage explants maintained in the presence of insulin-like growth factor I. Connect Tissue Res 1991, 26:101-120. 10.3109/03008209109152167, 1905608.
22. Luyten FP, Hascall VC, Nissley SP, Morales TI, Reddi AH. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys 1988, 267:416-425. 10.1016/0003-9861(88)90047-1, 3214163.
23. Sah RL, Chen AC, Grodzinsky AJ, Trippel SB. Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. Arch Biochem Biophys 1994, 308:137-147. 10.1006/abbi.1994.1020, 8311446.
24. van Osch GJ, van der Veen SW, Buma P, Verwoerd-Verhoef HL. Effect of transforming growth factor-beta on proteoglycan synthesis by chondrocytes in relation to differentiation stage and the presence of pericellular matrix. Matrix Biol 1998, 17:413-424. 10.1016/S0945-053X(98)90101-9, 9840443.
25. van Osch GJ, van den Berg WB, Hunziker EB, Hauselmann HJ. Differential effects of IGF-1 and TGF beta-2 on the assembly of proteoglycans in pericellular and territorial matrix by cultured bovine articular chondrocytes. Osteoarthritis Cartilage 1998, 6:187-195. 10.1053/joca.1998.0111, 9682785.
26. van Susante JL, Buma P, van Beuningen HM, van den Berg WB, Veth RP. Responsiveness of bovine chondrocytes to growth factors in medium with different serum concentrations. J Orthop Res 2000, 18:68-77. 10.1002/jor.1100180111, 10716281.
27. Osborn KD, Trippel SB, Mankin HJ. Growth factor stimulation of adult articular cartilage. J Orthop Res 1989, 7:35-42. 10.1002/jor.1100070106, 2642302.
28. Cancedda R, Descalzi CF, Castagnola P. Chondrocyte differentiation. Int Rev Cytol 1995, 159:265-358.
29. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998, 238:265-272. 10.1006/excr.1997.3858, 9457080.
30. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998, 4:415-428. 10.1089/ten.1998.4.415, 9916173.
31. Matsuda C, Takagi M, Hattori T, Wakitani S, Yoshida T. Differentiation of human bone marrow mesenchymal stem cells to chondrocytes for construction of three-dimensional cartilage tissue. Cytotechnology 2005, 47:11-17. 10.1007/s10616-005-3751-x, 3449815, 19003040.
32. Bujia J. Effect of growth factors on cell proliferation and matrix synthesis in cultured human chondrocytes. Laryngorhinootologie 1995, 74:444-449. 10.1055/s-2007-997777, 7669137.
33. Pei M, Seidel J, Vunjak-Novakovic G, Freed LE. Growth factors for sequential cellular de- and re-differentiation in tissue engineering. Biochem Biophys Res Commun 2002, 294:149-154. 10.1016/S0006-291X(02)00439-4, 12054755.
34. Zimber MP, Tong B, Dunkelman N, Pavelec R, Grande D, New L, Purchio AF. Tgf-Beta promotes the growth of bovine chondrocytes in monolayer culture and the formation of cartilage tissue on three-dimensional scaffolds. Tissue Eng 1995, 1:289-300. 10.1089/ten.1995.1.289, 19877907.
35. Redini F, Galera P, Mauviel A, Loyau G, Pujol JP. Transforming growth factor beta stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes. FEBS Lett 1988, 234:172-176. 10.1016/0014-5793(88)81327-9, 3164687.
36. Pujol JP, Galera P, Pronost S, Boumediene K, Vivien D, Macro M, Min W, Redini F, Penfornis H, Daireaux M. Transforming growth factor-beta (TGF-beta) and articular chondrocytes. Ann Endocrinol (Paris) 1994, 55:109-120.
37. Galera P, Vivien D, Pronost S, Bonaventure J, Redini F, Loyau G, Pujol JP. Transforming growth factor-beta-1 (TGF-beta-1) up-regulation of collagen type-II in primary cultures of rabbit articular chondrocytes (Rac) involves increased messenger-RNA levels without affecting messenger-RNA stability and procollagen processing. J Cell Physiol 1992, 153:596-606. 10.1002/jcp.1041530322, 1447320.
38. Galera P, Redini F, Vivien D, Bonaventure J, Penfornis H, Loyau G, Pujol JP. Effect of transforming growth factor-beta-1 (TGF-beta-1) on matrix synthesis by monolayer-cultures of rabbit articular chondrocytes during the dedifferentiation process. Exp Cell Res 1992, 200:379-392. 10.1016/0014-4827(92)90186-C, 1572404.
39. van der Kraan PM, Vitters E, van den BW. Differential effect of transforming growth factor beta on freshly isolated and cultured articular chondrocytes. J Rheumatol 1992, 19:140-145.
40. van der Kraan PM, Vitters EL, van den Berg WB. Inhibition of proteoglycan synthesis by transforming growth factor beta in anatomically intact articular cartilage of murine patellae. Ann Rheum Dis 1992, 51:643-647. 10.1136/ard.51.5.643, 1005698, 1616330.
41. Chu CR, Szczodry M, Bruno S. Animal models for cartilage regeneration and repair. Tissue Eng Part B Rev 2010, 16:105-115. 10.1089/ten.teb.2009.0452, 3121784, 19831641.
42. Hunter CJ, Levenston ME. Maturation and integration of tissue-engineered cartilages within an in vitro defect repair model. Tissue Eng 2004, 10:736-746. 10.1089/1076327041348310, 15265290.
43. Vinardell T, Thorpe SD, Buckley CT, Kelly DJ. Chondrogenesis and integration of mesenchymal stem cells within an in vitro cartilage defect repair model. Ann Biomed Eng 2009, 37:2556-2565. 10.1007/s10439-009-9791-1, 19757060.
44. Obradovic B, Martin I, Padera RF, Treppo S, Freed LE, Vunjak-Novakovic G. Integration of engineered cartilage. J Orthop Res 2001, 19:1089-1097. 10.1016/S0736-0266(01)00030-4, 11781010.
45. DiMicco MA, Waters SN, Akeson WH, Sah RL. Integrative articular cartilage repair: dependence on developmental stage and collagen metabolism. Osteoarthritis Cartilage 2002, 10:218-25. 10.1053/joca.2001.0502, 11869083.
46. Hestrin S, Schramm M. Synthesis of cellulose by Acetobacter xylinum. II. Preparation of freeze-dried cells capable of polymerizing glucose to cellulose. Biochem J 1954, 58:345-352. 1269899, 13208601.
47. Pretzel D, Pohlers D, Weinert S, Kinne RW. In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage. Arthritis Res Ther 2009, 11:R25. 10.1186/ar2618, 2688258, 19226472.
48. Chandrasekhar S, Esterman MA, Hoffman HA. Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem 1987, 161:103-108. 10.1016/0003-2697(87)90658-0, 3578776.
49. Secretan C, Bagnall KM, Jomha NM. Effects of introducing cultured human chondrocytes into a human articular cartilage explant model. Cell Tissue Res 2010, 339:421-427. 10.1007/s00441-009-0901-z, 20012649.
50. Hung CT, Lima EG, Mauck RL, Takai E, LeRoux MA, Lu HH, Stark RG, Guo XE, Ateshian GA. Anatomically shaped osteochondral constructs for articular cartilage repair. J Biomech 2003, 36:1853-1864. 10.1016/S0021-9290(03)00213-6, 14614939.
51. Kuo CK, Li WJ, Mauck RL, Tuan RS. Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol 2006, 18:64-73. 10.1097/01.bor.0000198005.88568.df, 16344621.
52. Lima EG, Mauck RL, Han SH, Park S, Ng KW, Ateshian GA, Hung CT. Functional tissue engineering of chondral and osteochondral constructs. Biorheology 2004, 41:577-590.
53. Huang AH, Farrell MJ, Mauck RL. Mechanics and mechanobiology of mesenchymal stem cell-based engineered cartilage. J Biomech 2010, 43:128-136. 10.1016/j.jbiomech.2009.09.018, 2813425, 19828149.
54. Aurich M, Squires GR, Reiner A, Mollenhauer JA, Kuettner KE, Poole AR, Cole AA. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints. Arthritis Rheum 2005, 52:112-119. 10.1002/art.20740, 15641059.
55. Squires GR, Okouneff S, Ionescu M, Poole AR. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 2003, 48:1261-1270. 10.1002/art.10976, 12746899.
56. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997, 99:1534-1545. 10.1172/JCI119316, 507973, 9119997.
57. Pratta MA, Yao WQ, Decicco C, Tortorella MD, Liu RQ, Copeland RA, Magolda R, Newton RC, Trzaskos JM, Arner EC. Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem 2003, 278:45539-45545. 10.1074/jbc.M303737200, 12890681.
58. LaPrade RF, Bursch LS, Olson EJ, Havlas V, Carlson CS. Histologic and immunohistochemical characteristics of failed articular cartilage resurfacing procedures for osteochondritis of the knee: a case series. Am J Sports Med 2008, 36:360-368. 10.1177/0363546507308359, 18006675.
59. Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982, 30:215-224. 10.1016/0092-8674(82)90027-7, 7127471.
60. Schnabel M, Marlovits S, Eckhoff G, Fichtel I, Gotzen L, Vecsei V, Schlegel J. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 2002, 10:62-70. 10.1053/joca.2001.0482, 11795984.
61. Chang C, Lauffenburger DA, Morales TI. Motile chondrocytes from newborn calf: migration properties and synthesis of collagen II. Osteoarthritis Cartilage 2003, 11:603-612. 10.1016/S1063-4584(03)00087-6, 12880583.
62. Frenkel SR, Clancy RM, Ricci JL, Di Cesare PE, Rediske JJ, Abramson SB. Effects of nitric oxide on chondrocyte migration, adhesion, and cytoskeletal assembly. Arthritis Rheum 1996, 39:1905-1912. 10.1002/art.1780391118, 8912514.
63. Gosiewska A, Rezania A, Dhanaraj S, Vyakarnam M, Zhou J, Burtis D, Brown L, Kong W, Zimmerman M, Geesin JC. Development of a three-dimensional transmigration assay for testing cell--polymer interactions for tissue engineering applications. Tissue Eng 2001, 7:267-277. 10.1089/10763270152044134, 11429147.
64. Morales TI. Chondrocyte moves: clever strategies?. Osteoarthritis Cartilage 2007, 15:861-871. 10.1016/j.joca.2007.02.022, 1994785, 17467303.
65. Hunziker EB, Rosenberg LC. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am 1996, 78:721-733.
66. Winnemoller M, Schmidt G, Kresse H. Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol 1991, 54:10-17.
67. Davies LC, Blain EJ, Caterson B, Duance VC. Chondroitin sulphate impedes the migration of a sub-population of articular cartilage chondrocytes. Osteoarthritis Cartilage 2008, 16:855-864. 10.1016/j.joca.2007.12.005, 18222711.
68. Bruns J, Kersten P, Silbermann M, Lierse W. Cartilage-flow phenomenon and evidence for it in perichondrial grafting. Arch Orthop Trauma Surg 1997, 116:66-73. 10.1007/BF00434104, 9006769.
69. Calandruccio RA, Gilmer WS. Proliferation, regeneration, and repair of articular cartilage of immature animals. J Bone Joint Surg Am 1962, 44:431-455.
70. Buckwalter JA, Mankin HJ. Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 1998, 47:487-504.
71. Martinek V. Anatomy and pathophysiology of articular cartilage. Deutsche Zeit Sportmed 2003, 54:166-170.
72. Darling EM, Athanasiou KA. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res 2005, 23:425-432. 10.1016/j.orthres.2004.08.008, 15734258.
73. Kaps C, Fuchs S, Endres M, Vetterlein S, Krenn V, Perka C, Sittinger M. Molecular characterization of tissue-engineered articular chondrocyte transplants based on resorbable polymer fleece. Orthopade 2004, 33:76-85. 10.1007/s00132-003-0505-3, 14747914.
74. Velikonja NK, Wozniak G, Malicev E, Knezevic M, Jeras M. Protein synthesis of human articular chondrocytes cultured in vitro for autologous transplantation. Pflugers Arch 2001, 442:R169-R170. 10.1007/s004240100012, 11678327.
75. Anders JO, Mollenhauer J, Beberhold A, Kinne RW, Venbrocks RA. Gelatin-based haemostyptic Spongostan as a possible three-dimensional scaffold for a chondrocyte matrix? An experimental study with bovine chondrocytes. J Bone Joint Surg Br 2009, 91B:409-416.
76. Goldberg AJ, Lee DA, Bader DL, Bentley G. Autologous chondrocyte implantation. Culture in a TGF-beta-containing medium enhances the re-expression of a chondrocytic phenotype in passaged human chondrocytes in pellet culture. J Bone Joint Surg Br 2005, 87:128-134.
77. Getgood A, Brooks R, Fortier L, Rushton N. Articular cartilage tissue engineering: today's research, tomorrow's practice?. J Bone Joint Surg Br 2009, 91:565-576.
78. Vinatier C, Mrugala D, Jorgensen C, Guicheux J, Noel D. Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 2009, 27:307-314. 10.1016/j.tibtech.2009.02.005, 19329205.
79. Stoddart MJ, Grad S, Eglin D, Alini M. Cells and biomaterials in cartilage tissue engineering. Regen Med 2009, 4:81-98. 10.2217/17460751.4.1.81, 19105618.
80. Jones AR, Flannery CR. Bioregulation of lubricin expression by growth factors and cytokines. Eur Cell Mater 2007, 13:40-45.
81. Khalafi A, Schmid TM, Neu C, Reddi AH. Increased accumulation of superficial zone protein (SZP) in articular cartilage in response to bone morphogenetic protein-7 and growth factors. J Orthop Res 2007, 25:293-303. 10.1002/jor.20329, 17143906.
82. Schmidt TA, Gastelum NS, Han EH, Nugent-Derfus GE, Schumacher BL, Sah RL. Differential regulation of proteoglycan 4 metabolism in cartilage by IL-1 alpha, IGF-1, and TGF-beta 1. Osteoarthritis Cartilage 2008, 16:90-97. 10.1016/j.joca.2007.05.009, 17596975.
83. Hui W, Rowan AD, Cawston T. Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-beta1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha. Cytokine 2001, 16:31-35. 10.1006/cyto.2001.0950, 11669584.
84. Qureshi HY, Sylvester J, El Mabrouk M, Zafarullah M. TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. J Cell Physiol 2005, 203:345-352. 10.1002/jcp.20228, 15468069.
85. Su S, DiBattista JA, Sun Y, Li WQ, Zafarullah M. Up-regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in articular chondrocytes is mediated by serine/threonine and tyrosine kinases. J Cell Biochem 1998, 70:517-527. 10.1002/(SICI)1097-4644(19980915)70:4<517::AID-JCB8>3.0.CO;2-M, 9712149.
86. Enders JT, Otto TJ, Peters HC, Wu J, Hardouin S, Moed BR, Zhang Z. A model for studying human articular cartilage integration in vitro. J Biomed Mater Res A 2010, 94:509-514.
87. Steinert AF, Ghivizzani SC, Rethwilm A, Tuan RS, Evans CH, Noth U. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther 2007, 9:213-227. 10.1186/ar2195, 2206353, 17561986.
88. Esguerra M, Fink H, Laschke MW, Jeppsson A, Delbro D, Gatenholm P, Menger MD, Risberg B. Intravital fluorescent microscopic evaluation of bacterial cellulose as scaffold for vascular grafts. J Biomed Mater Res A 2010, 93:140-149.
89. Moreira S, Silva NB, Almeida-Lima J, Rocha HA, Medeiros SR, Alves C, Gama FM. BC nanofibres: in vitro study of genotoxicity and cell proliferation. Toxicol Lett 2009, 189:235-241. 10.1016/j.toxlet.2009.06.849, 19524649.
90. Zahedmanesh H, Mackle JN, Sellborn A, Drotz K, Bodin A, Gatenholm P, Lally C. Bacterial cellulose as a potential vascular graft: mechanical characterization and constitutive model development. J Biomed Mater Res B Appl Biomater 2011, 97:105-113.
91. Hua N, Sun J. Body distribution of poly(D,L-lactide-co-glycolide) copolymer degradation products in rats. J Mater Sci Mater Med 2008, 19:3243-3248. 10.1007/s10856-008-3460-z, 18470703.
92. Rambo CR, Recouvreux DOS, Carminatti CA, Pitlovanciv AK, Antonio RV, Porto LM. Template assisted synthesis of porous nanofibrous cellulose membranes for tissue engineering. Mat Sci Eng C-Bio S 2008, 28:549-554.